In addition, it is reported that SP1 was verified as a target for miR-24, miR-24/SP pathway should help us understand the radiosensitivity mechanisms of human NPC, which may be a potential therapeutic target [20]. This evidence concerns the gene SP1 and nasopharyngeal carcinoma.